Corrigendum to “Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration” [Journal of Genetics and Genomics (2022) 49, 1114–1126]

doi: 10.1016/j.jgg.2024.04.009

• Xi Chen ^a , 
• Xuran Niu ^a , 
• Yang Liu ^b , 
• Rui Zheng ^c , 
• Lei Yang ^a , 
• Jian Lu ^a , 
• Shuming Yin ^a , 
• Yu Wei ^a , 
• Jiahao Pan ^a , 
• Ahmed Sayed ^d , 
• Xueyun Ma ^a , 
• Meizhen Liu ^a , 
• Fengxiang Jing ^e , 
• Mingyao Liu ^a , 
• Jiazhi Hu ^b     , 
• Liren Wang ^a     , 
• Dali Li ^a    

•  

  a. Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China;

•  

  b. The MOE Key Laboratory of Cell Proliferation and Differentiation, Genome Editing Research Center, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China;

•  

  c. Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;

•  

  d. Biochemistry Laboratory, Chemistry Department, Faculty of Science, Assiut University, Assiut 71516, Egypt;

•  

  e. Shanghai Turtle Technology Co., Shanghai 201900, China